Impact of the IRA on Biosimilar Development
-
Session description to come.
Association for Accessible Medicines
601 New Jersey Ave NW, Suite 850
Washington, DC 20001
P: 202.249.7100
E: [email protected]
-
Session description to come.
Association for Accessible Medicines
601 New Jersey Ave NW, Suite 850
Washington, DC 20001
P: 202.249.7100
E: [email protected]
Association for Accessible Medicines
Biosimilars Council